The Prescription Drug User Fee Act target action date for the NDA is scheduled for 24 July 2026.

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

If you or someone you care about has ADHD and you have started to give up hope that things will get better, you might consider trying psychotherapy or coaching. I treat many people that come to me ...

Focus ADHD is an online psychiatric clinic based in Des Moines, Iowa, offering personalized treatment for adult professionals living with ADHD. The clinic provides expert medication management, ...

Health and well-being don't jump to mind when discussing adult ADHD, and neither do poor health, suffering, disability, and ...

Attention deficit hyperactivity disorder (ADHD) is a risk factor for co-occurring psychiatric disorders and negative psychosocial consequences in adulthood. Previous trials of psychotherapeutic ...

ADHD diagnosis, which largely originated in the United States, began to spread to the rest of the globe in the late 1990s, ...

Gendered diagnosis screening may be necessary.

Despite decades of research, these ADHD myths still affect how people understand attention and behavior.

Following the changes made today, more New Zealanders with ADHD will have faster access to support as a result of changes to ...

Long-term methylphenidate use in childhood links to higher adult BMI and slightly shorter height, underscoring the need for ...

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...